Psoriasis and Distractibility

Summary:

Distractibility is found among people with Psoriasis, especially for people who are female, 20-29 old.

The study analyzes which people have Distractibility with Psoriasis. It is created by eHealthMe based on reports of 19 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,479 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Distractibility?

Distractibility (inability to sustain one's attention) is found to be associated with 121 drugs and 303 conditions by eHealthMe. Check the latest studies of Distractibility.



On Jul, 12, 2026

19 people who have Psoriasis and Distractibility are studied.

Would you have Distractibility when you have Psoriasis?

Gender of people who have Psoriasis and experienced Distractibility *:

  • female: 68.42 %
  • male: 31.58 %

Age of people who have Psoriasis and experienced Distractibility *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 50 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 25 %

Common co-existing conditions for these people *:

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 8 people, 42.11%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 21.05%
  3. Depression: 2 people, 10.53%
  4. Stress And Anxiety: 1 person, 5.26%
  5. Pain: 1 person, 5.26%

Common drugs taken by these people *:

  1. Dovonex: 8 people, 42.11%
  2. Vitamin B6: 7 people, 36.84%
  3. Humira: 5 people, 26.32%
  4. Cosentyx: 4 people, 21.05%
  5. Otezla: 3 people, 15.79%
  6. Zoloft: 2 people, 10.53%
  7. Xeljanz Xr: 2 people, 10.53%
  8. Mesalamine: 2 people, 10.53%
  9. Folic Acid: 2 people, 10.53%
  10. Dilaudid: 2 people, 10.53%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 9 people, 47.37%
  2. Hypotension (abnormally low blood pressure): 9 people, 47.37%
  3. Hypoaesthesia (reduced sense of touch or sensation): 8 people, 42.11%
  4. Sinusitis (inflammation of sinus): 8 people, 42.11%
  5. Gastroenteritis (inflammation of stomach and intestine): 8 people, 42.11%
  6. Glossodynia (a burning or painful sensation in the tongue): 8 people, 42.11%
  7. Heart Rate Increased: 8 people, 42.11%
  8. Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 8 people, 42.11%
  9. Memory Loss: 8 people, 42.11%
  10. Menstrual Disorder (disease of menstrual cycle): 8 people, 42.11%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Distractibility?

- Check whether Distractibility is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Distractibility:

All the conditions that are associated with Distractibility:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Distractibility and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: